Does EMICIZUMAB-KXWH Cause Product packaging quantity issue? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product packaging quantity issue have been filed in association with EMICIZUMAB-KXWH. This represents 0.1% of all adverse event reports for EMICIZUMAB-KXWH.
6
Reports of Product packaging quantity issue with EMICIZUMAB-KXWH
0.1%
of all EMICIZUMAB-KXWH reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From EMICIZUMAB-KXWH?
Of the 6 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMICIZUMAB-KXWH. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does EMICIZUMAB-KXWH Cause?
Haemorrhage (3,612)
No adverse event (654)
Off label use (542)
Haemarthrosis (487)
Fall (484)
Arthralgia (385)
Contusion (321)
Epistaxis (313)
Pain (260)
Head injury (248)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which EMICIZUMAB-KXWH Alternatives Have Lower Product packaging quantity issue Risk?
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN\LINAGLIPTIN
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN\METFORMIN
EMICIZUMAB-KXWH vs EMSAM